Lipid-enriched enteral nutrition controls the inflammatory response in murine Gram-negative sepsis

Critical Care Medicine

Volumn 38, Issue 10, 2010, Pages 1996-2002

  Lubbers, Tim ^a   De Haan, Jacco Juri ^a   Hadfoune, M'Hamed ^a   Zhang, Yiren ^c   Luyer, Misha D ^a,b   Grundy, David ^c   Buurman, Wim A ^a   Greve, Jan Willem ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

cholecystokinin receptors; enteral nutrition; Gram negative sepsis; inflammation; lipid; nicotinic receptors; vagal anti inflammatory pathway

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; ANTIINFLAMMATORY AGENT; CHLORISONDAMINE; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE; ILEUM LIPID BINDING PROTEIN; LIPID; LIPID BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIVER PROTEIN; MACROGOL 20000; NICOTINIC RECEPTOR; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLCHOLINE; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BENZODIAZEPINE DERIVATIVE; CARBANILAMIDE DERIVATIVE; LIPOPOLYSACCHARIDE, E COLI O55-B5;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; ENTERIC FEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GRAM NEGATIVE SEPSIS; IMMUNOHISTOCHEMISTRY; INTESTINE; INTESTINE INJURY; ISOLATED ORGAN; LIPID DIET; LOW DRUG DOSE; MALE; MOUSE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STOMACH DISTENSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; COMPLICATION; DISEASE MODEL; ENDOTOXEMIA; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PROCEDURES; SEPSIS;

ANIMALS; BENZODIAZEPINONES; CHLORISONDAMINE; DEVAZEPIDE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENTERAL NUTRITION; INFLAMMATION; LIPIDS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; PHENYLUREA COMPOUNDS; RECEPTORS, CHOLECYSTOKININ; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957239314     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181eb90d7     Document Type: Article

References (52)

1. Angus DC, Wax RS: Epidemiology of sepsis: An update. Crit Care Med 2001; 29:S109-S116
2. Riedemann NC, Guo RF, Ward PA: Novel strategies for the treatment of sepsis. Nat Med 2003; 9:517-524
3. Tracey KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986; 234: 470-474
4. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251
5. Barriere SL, Lowry SF: An overview of mortality risk prediction in sepsis. Crit Care Med 1995; 23:376-393
6. Talmor M, Hydo L, Barie PS: Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg 1999; 134:81-87
7. Rubulotta FM, Ramsay G, Parker MM, et al: An international survey: Public awareness and perception of sepsis. Crit Care Med 2009; 37:167-170
8. Abraham E, Laterre PF, Garbino J, et al: Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med 2001; 29:503-510
9. Parrish WR, Gallowitsch-Puerta M, Czura CJ, et al: Experimental therapeutic strategies for severe sepsis: Mediators and mechanisms. Ann N Y Acad Sci 2008; 1144:210-236
10. Pavlov VA, Wang H, Czura CJ, et al: The cholinergic anti-inflammatory pathway: A missing link in neuroimmunomodulation. Mol Med 2003; 9:125-134
11. Fleshner M, Goehler LE, Schwartz BA, et al: Thermogenic and corticosterone responses to intravenous cytokines (IL-1beta and TNF-alpha) are attenuated by subdiaphragmatic vagotomy. J Neuroimmunol 1998; 86: 134-141
12. Wang H, Yu M, Ochani M, et al: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-388
13. Zanden EP, Snoek SA, Heinsbroek SE, et al: Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic ace-tylcholine receptor alpha4beta2. Gastroen-terology 2009; 137:1029-1039
14. Van Westerloo DJ, Giebelen IA, Florquin S, et al: The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005; 191: 2138-2148
15. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462
16. De Haan JJ, Lubbers T, Hadfoune M, et al: Postshock intervention with high-lipid en-teral nutrition reduces inflammation and tissue damage. Ann Surg 2008; 248:842-848
17. Luyer MD, Jacobs JA, Vreugdenhil AC, et al: Enteral administration of high-fat nutrition before and directly after hemorrhagic shock reduces endotoxemia and bacterial transloca-tion. Ann Surg 2004; 239:257-264
18. Lubbers T, Luyer MD, de Haan JJ, et al: Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of chole-cystokinin- receptors. Ann Surg 2009; 249: 481-487
19. Luyer MD, Greve JW, Hadfoune M, et al: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005; 202:1023-1029
20. Rong W, Keating C, Sun B, et al: Purinergic contribution to small intestinal afferent hy-persensitivity in a murine model of postinfectious bowel disease. Neurogastroenterol Motil 2009; 21:665-671
21. Booth CE, Kirkup AJ, Hicks GA, et al: Soma-tostatin sst(2) receptor-mediated inhibition of mesenteric afferent nerves of the jejunum in the anesthetized rat. Gastroenterology 2001; 121:358-369
22. Han X, Fink MP, Yang R, et al: Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotox-emic mice. Shock 2004; 21:261-270
23. Clark JA, Coopersmith CM: Intestinal crosstalk: A new paradigm for understanding the gut as the 'motor' of critical illness. Shock 2007; 28:384-393
24. Han X, Fink MP, Delude RL: Proinflamma-tory cytokines cause NO*-dependent and-independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 2003; 19: 229-237
25. Richards W, Hillsley K, Eastwood C, et al: Sensitivity of vagal mucosal afferents to cho-lecystokinin and its role in afferent signal transduction in the rat. J Physiol 1996; 497: 473-481
26. Schwartz GJ, McHugh PR, Moran TH: Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol 1993; 265:R872-R876
27. Van De Wall EH, Duffy P, Ritter RC: CCK enhances response to gastric distension by acting on capsaicin-insensitive vagal affer-ents. Am J Physiol Regul Integr Comp Physiol 2005; 289:R695-R703
28. Bozkurt A, Oktar BK, Kurtel H, et al: Capsa-icin-sensitive vagal fibres and 5-HT3-, gas-trin releasing peptide-and cholecystokinin A-receptors are involved in distension-induced inhibition of gastric emptying in the rat. Regul Pept 1999; 83:81-86
29. Pilichiewicz AN, Papadopoulos P, Brennan IM, et al: Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2007; 293:R2170-R2178
30. Eastwood C, Maubach K, Kirkup AJ, et al: The role of endogenous cholecystokinin in the sensory transduction of luminal nutrient signals in the rat jejunum. Neurosci Lett 1998; 254:145-148
31. Deitch EA, Berg R, Specian R: Endotoxin promotes the translocation of bacteria from the gut. Arch Surg 1987; 122:185-190
32. Sun XM, Hsueh W: Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988; 81:1328-1331
33. Beutler B, Milsark IW, Cerami AC: Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-871
34. Clark JA, Gan H, Samocha AJ, et al: Entero-cyte-specific epidermal growth factor prevents barrier dysfunction and improves mortality in murine peritonitis. Am J Physiol Gastrointest Liver Physiol 2009; 297: G471-G479
35. De Haan JJ, Lubbers T, Derikx JP, et al: Rapid development of intestinal cell damage following severe trauma: A prospective observational cohort study. Crit Care 2009; 13:R86
36. Derikx JP, van Waardenburg DA, Thuijls G, et al: New insight in loss of gut barrier during major non-abdominal surgery. PLoS One 2008; 3:e3954
37. Derikx JP, Bijker EM, Vos GD, et al: Gut mucosal cell damage in meningococcal sepsis in children: Relation with clinical outcome. Crit Care Med 2009; 38:133-137
38. Derikx JP, Poeze M, van Bijnen AA, et al: Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock 2007; 28:544-548
39. Dhainaut JF, Marin N, Mignon A, et al: Hepatic response to sepsis: Interaction between coagulation and inflammatory processes. Crit Care Med 2001; 29:S42-S47
40. Altamura M, Caradonna L, Amati L, et al: Splenectomy and sepsis: The role of the spleen in the immune-mediated bacterial clearance. Immunopharmacol Immunotoxi-col 2001; 23:153-161
41. Ge Y, Ezzell RM, Clark BD, et al: Relationship of tissue and cellular interleukin-1 and lipopolysaccharide after endotoxemia and bacte-remia. J Infect Dis 1997; 176:1313-1321
42. Katagiri H, Ito Y, Ito S, et al: TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock 2008; 30:463-467
43. Tracey KJ, Wei H, Manogue KR, et al: Ca-chectin/tumor necrosis factor induces ca-chexia, anemia, and inflammation. J Exp Med 1988; 167:1211-1227
44. Mabley JG, Pacher P, Szabo C: Activation of the cholinergic antiinflammatory pathway reduces ricin-induced mortality and organ failure in mice. Mol Med 2009; 15:166-172
45. Rosas-Ballina M, Ochani M, Parrish WR, et al: Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Nat Acad Sci\USA 2008; 105:11008-11013
46. Li B, Li YM, Li X, et al: COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats. J Surg Res 2009; 157:43-47
47. Luyer MD, Derikx JP, Beyaert R, et al: High-fat nutrition reduces hepatic damage following exposure to bacterial DNA and hemor-rhagic shock. J Hepatol 2009; 50:342-350
48. Herndon DN, Hart DW, Wolf SE, et al: Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001; 345: 1223-1229
49. Ackland GL, Yao ST, Rudiger A, et al: Car-dioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med 2010; 38:388-394
50. Elke G, Schadler D, Engel C, et al: Current practice in nutritional support and its association with mortality in septic patients\Results from a national, prospective, multi-center study. Crit Care Med 2008; 36: 1762-1767
51. Bisgaard T, Kehlet H: Early oral feeding after elective abdominal surgery\What are the issues? Nutrition 2002; 18:944-948
52. Bengmark S: Enteral nutrition in HPB surgery: past and future. J Hepatobiliary Pan-creat Surg 2002; 9:448-458